Pediatrix Medical Group (NYSE:MD) Announces Earnings Results, Beats Estimates By $0.07 EPS

Pediatrix Medical Group (NYSE:MD) issued its quarterly earnings data on Friday. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07, Briefing.com reports. The company had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. Pediatrix Medical Group’s revenue for the quarter was up .9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.29 earnings per share.

Pediatrix Medical Group Trading Up 23.5 %

MD stock opened at $15.21 on Friday. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $15.42. The business’s 50-day moving average is $11.54 and its 200 day moving average is $9.36. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.87. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -5.02, a PEG ratio of 1.96 and a beta of 1.56.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Jefferies Financial Group raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $8.00 to $14.00 in a report on Thursday, September 26th. UBS Group boosted their price target on Pediatrix Medical Group from $9.00 to $10.50 and gave the company a “neutral” rating in a research note on Friday, August 9th. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. Finally, Truist Financial raised their target price on shares of Pediatrix Medical Group from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Monday, October 7th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $10.90.

Insider Activity

In other Pediatrix Medical Group news, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total transaction of $78,120.00. Following the sale, the director now owns 30,805 shares of the company’s stock, valued at $343,783.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Pediatrix Medical Group news, Director Laura A. Linynsky sold 7,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total value of $78,120.00. Following the transaction, the director now directly owns 30,805 shares of the company’s stock, valued at $343,783.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO James D. Swift sold 11,100 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the transaction, the chief executive officer now owns 170,001 shares in the company, valued at approximately $1,834,310.79. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock worth $701,889 over the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.